CY2341B1 - Bicyclic amino acids. - Google Patents

Bicyclic amino acids.

Info

Publication number
CY2341B1
CY2341B1 CY0300028A CY0300028A CY2341B1 CY 2341 B1 CY2341 B1 CY 2341B1 CY 0300028 A CY0300028 A CY 0300028A CY 0300028 A CY0300028 A CY 0300028A CY 2341 B1 CY2341 B1 CY 2341B1
Authority
CY
Cyprus
Prior art keywords
amino acids
bicyclic amino
bicyclic
acids
amino
Prior art date
Application number
CY0300028A
Other languages
English (en)
Inventor
Beate Diefenbach
Simon Goodman
Joachim Marz
Peter Raddatz
Friedrich Rippmann
Matthias Wiesner
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of CY2341B1 publication Critical patent/CY2341B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/20—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Communicable Diseases (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CY0300028A 1997-02-13 2003-03-17 Bicyclic amino acids. CY2341B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19705450A DE19705450A1 (de) 1997-02-13 1997-02-13 Bicyclische aromatische Aminosäuren

Publications (1)

Publication Number Publication Date
CY2341B1 true CY2341B1 (en) 2004-02-06

Family

ID=7820093

Family Applications (1)

Application Number Title Priority Date Filing Date
CY0300028A CY2341B1 (en) 1997-02-13 2003-03-17 Bicyclic amino acids.

Country Status (25)

Country Link
EP (1) EP0964856B1 (cs)
JP (1) JP4327257B2 (cs)
KR (1) KR20000071030A (cs)
CN (1) CN1085205C (cs)
AR (1) AR010894A1 (cs)
AT (1) ATE225776T1 (cs)
AU (1) AU735313B2 (cs)
BR (1) BR9807345A (cs)
CA (1) CA2280727C (cs)
CY (1) CY2341B1 (cs)
CZ (1) CZ297366B6 (cs)
DE (2) DE19705450A1 (cs)
DK (1) DK0964856T3 (cs)
ES (1) ES2183332T3 (cs)
HU (1) HUP0001138A3 (cs)
ID (1) ID22533A (cs)
NO (1) NO313289B1 (cs)
PL (1) PL335101A1 (cs)
PT (1) PT964856E (cs)
RU (1) RU2187506C2 (cs)
SI (1) SI0964856T1 (cs)
SK (1) SK284646B6 (cs)
TR (1) TR199901962T2 (cs)
WO (1) WO1998035949A1 (cs)
ZA (1) ZA981178B (cs)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040063790A1 (en) * 1996-05-31 2004-04-01 The Scripps Research Institute Methods for inhibition of angiogenesis
ES2381591T3 (es) 1998-04-09 2012-05-29 Meiji Seika Pharma Co., Ltd. Derivados de aminopiperidina como antagonistas de integrina alfa v beta 3
US7125883B1 (en) 1999-04-13 2006-10-24 Abbott Gmbh & Co. Kg Integrin receptor ligands
AU6316900A (en) 1999-08-05 2001-03-05 Meiji Seika Kaisha Ltd. Omega-amino-alpha-hydroxycarboxylic acid derivatives having integrin alphavbeta3antagonism
EP1244616A1 (en) * 1999-12-24 2002-10-02 SmithKline Beecham plc (hetero)bicyclylmethanesulfonylamino-substituted hydroxamic acid derivatives
EP1170287B1 (en) * 2000-01-25 2003-12-03 Kaneka Corporation Process for preparation of optically active n-substituted azetidine-2-carboxylic acids
DE60136748D1 (de) * 2000-11-01 2009-01-08 Merck Patent Gmbh Verfahren und zusammensetzungen zur behandlung von augenerkrankungen
CA2449054C (en) 2001-05-30 2011-01-04 The Scripps Research Institute Integrin targeting liposome for nucleic acid delivery
PT1411926E (pt) * 2001-08-01 2005-10-31 Merck Patent Gmbh Inibidores de integrina para o tratamento de doencas oftalmicas
KR20040091002A (ko) * 2002-02-14 2004-10-27 메르크 파텐트 게엠베하 안질환을 치료하기 위한 방법 및 조성물
FR2847254B1 (fr) * 2002-11-19 2005-01-28 Aventis Pharma Sa Nouveaux derives antagonistes du recepteur de la vitronectine, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les refermant
DE10305784A1 (de) * 2003-02-12 2004-08-26 Merck Patent Gmbh Verfahren zur Herstellug bicyclischer aromatischer Aminosäuren sowie deren Zwischenprodukte
DE10337863A1 (de) 2003-08-18 2005-03-17 Merck Patent Gmbh Verwendung von Chromen-4-on-Derivaten
AU2005249586B2 (en) * 2004-06-04 2010-12-23 The Scripps Research Institute Compositions and methods for treatment of neovascular diseases
UA87854C2 (en) 2004-06-07 2009-08-25 Мерк Энд Ко., Инк. N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators
BRPI0924126B1 (pt) * 2008-12-26 2021-07-27 Sumitomo Dainippon Pharma Co., Ltd. Composto heterocíclico bicíclico, medicamento, inibidor de sns, composição farmacêutica e uso do referido composto
WO2011024987A1 (ja) * 2009-08-31 2011-03-03 塩野義製薬株式会社 芳香族縮合へテロ環誘導体およびそれらを含有する医薬組成物
EA201400976A1 (ru) 2012-03-06 2015-02-27 Бёрингер Ингельхайм Интернациональ Гмбх Бензодиоксаны в комбинации с другими активными средствами для ингибирования продуцирования лейкотриена
EP2885285B1 (en) 2012-07-17 2016-10-19 Boehringer Ingelheim International GmbH Pyrazole drivatives which inhibit leukotriene production
US9573957B2 (en) 2013-07-15 2017-02-21 Boehringer Ingelheim International Gmbh Inhibitors of leukotriene production
US9303018B2 (en) 2013-07-15 2016-04-05 Boehringer Ingelheim International Gmbh Inhibitors of leukotriene production
CN106572997A (zh) 2014-05-30 2017-04-19 辉瑞公司 作为选择性雄激素受体调节剂的腈衍生物
WO2023275715A1 (en) 2021-06-30 2023-01-05 Pfizer Inc. Metabolites of selective androgen receptor modulators
WO2023076679A1 (en) 2021-11-01 2023-05-04 Alkahest, Inc. Benzodioxane modulators of leukotriene a4 hydrolase (lta4h) for prevention and treatment of aging-associated diseases

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3151690A1 (de) * 1981-12-29 1983-07-07 Hoechst Ag, 6230 Frankfurt "neue derivate bicyclischer aminosaeuren, verfahren zu ihrer herstellung, diese enthaltende mittel und deren verwendung sowie neue bicyclische aminosaeuren als zwischenstufen und verfahren zu deren herstellung"
FR2674854B1 (fr) * 1991-04-04 1995-03-03 Bouchara Nouvelles quinolones leur procede de preparation et les compositions pharmaceutiques en refermant.
CA2150550A1 (en) * 1992-12-01 1994-06-09 Melissa S. Egbertson Fibrinogen receptor antagonists
AU701776B2 (en) * 1994-05-27 1999-02-04 Merck & Co., Inc. Compounds for inhibiting osteoclast-mediated bone resorption
DE19548709A1 (de) * 1995-12-23 1997-07-03 Merck Patent Gmbh Tyrosinderivate
CZ424998A3 (cs) * 1996-06-28 1999-03-17 Merck Patent Gmbh Deriváty fenylaminu jakožto integrinové inhibitory
DE19654483A1 (de) * 1996-06-28 1998-01-02 Merck Patent Gmbh Phenylalanin-Derivate

Also Published As

Publication number Publication date
TR199901962T2 (xx) 1999-12-21
PT964856E (pt) 2003-02-28
CN1085205C (zh) 2002-05-22
DK0964856T3 (da) 2003-02-10
JP2001511789A (ja) 2001-08-14
JP4327257B2 (ja) 2009-09-09
DE19705450A1 (de) 1998-08-20
KR20000071030A (ko) 2000-11-25
CZ297366B6 (cs) 2006-11-15
SK284646B6 (sk) 2005-08-04
NO993901D0 (no) 1999-08-12
NO993901L (no) 1999-10-12
EP0964856A1 (de) 1999-12-22
CA2280727C (en) 2008-05-06
SK107199A3 (en) 2000-05-16
HUP0001138A2 (hu) 2001-05-28
CN1252064A (zh) 2000-05-03
WO1998035949A1 (de) 1998-08-20
NO313289B1 (no) 2002-09-09
EP0964856B1 (de) 2002-10-09
AU735313B2 (en) 2001-07-05
CZ287599A3 (cs) 1999-11-17
SI0964856T1 (en) 2003-04-30
HUP0001138A3 (en) 2002-10-28
BR9807345A (pt) 2000-03-21
ES2183332T3 (es) 2003-03-16
DE59805895D1 (de) 2002-11-14
ID22533A (id) 1999-10-28
AU6620698A (en) 1998-09-08
ATE225776T1 (de) 2002-10-15
CA2280727A1 (en) 1998-08-20
PL335101A1 (en) 2000-04-10
AR010894A1 (es) 2000-07-12
ZA981178B (en) 1999-05-21
RU2187506C2 (ru) 2002-08-20

Similar Documents

Publication Publication Date Title
CY2341B1 (en) Bicyclic amino acids.
DE69810130D1 (en) Rotationspumpe mit tauchrotor
GB9718609D0 (en) Fusion protein
HU9801045D0 (en) Substituted diamino-carboxylic acids
DE19881579D2 (en) Kompressor mit überlastenkopplungseinrichtung
GB9703681D0 (en) Protein complemention
GB9719879D0 (en) Protein
GB9718110D0 (en) Peptides
ZA965538B (en) Somatostatin peptides.
GB9700154D0 (en) Peptides
GB9715064D0 (en) Protein expression
AU1999999A (en) Contryphan peptides
ZA984322B (en) Sucrose-binding proteins
GB9720784D0 (en) Protein
GB9704559D0 (en) Protease
GB9719670D0 (en) Protein
GB9720785D0 (en) Protein
GB9703103D0 (en) Protein
GB9701024D0 (en) Peptides
GB9706556D0 (en) Peptides
GB9713146D0 (en) Peptides
GB9714075D0 (en) Novel protein
GB9703850D0 (en) Novel protein
GB9703827D0 (en) Novel protein
GB9704252D0 (en) Novel protein